AdvanCell
AdvanCell is a clinical-stage biotech developing targeted alpha therapies for cancer using lead-212 isotopes, with $453M in funding and 98 employees. Its Series D round in 2026 suggests strong investor confidence in its isotope supply platform.
The growth story
AdvanCell grew from 7 to 98 employees between 2021 and 2026, raising $453M along the way, most recently a Series D in July 2026.
About
AdvanCell makes radiopharmaceuticals that deliver alpha radiation directly to cancer cells via lead-212 isotopes, aiming to solve supply chain challenges in this emerging treatment class. Its therapies are in clinical trials, targeting cancers where precision radiation could improve outcomes.
The company has raised $453M, including a 2026 Series D, indicating sustained investor interest in its isotope production capabilities. With 98 staff, it operates at the intersection of drug discovery and nuclear medicine infrastructure.
Founders and leadership
Research dominates AdvanCell's workforce with 22 employees, reflecting its focus on drug development. The leadership team likely combines radiopharmaceutical expertise with operational experience given the dual demands of clinical trials and isotope supply chain management.
The AdvanCell org chart
Philina Lee (Chief Executive Officer) leads 37 mapped leaders with 7 direct reports. Click +N to expand a team; names link to the person’s public profile.
Departments, and which ones grew
Headcount by function: Research 35 (+17% YoY), Business Development 14 (+17% YoY), Engineering 7 (0% YoY), Operations 6 (+50% YoY), Quality Assurance 4 (+100% YoY), Administrative 3 (+200% YoY).
Talent flow
The University of Queensland is AdvanCell's top talent source (10 hires), followed by pharma companies like Novartis and Pfizer. Alumni have founded TrivarX and joined firms like AstraZeneca, showing mobility within specialized radiopharma.
Most common previous employers of AdvanCell staff: The University of Queensland (10), Novartis (5), Global Medical Solutions (GMS) (4), Vaxxas (3), Pfizer (3), POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company (3). Former AdvanCell employees most often moved to Varimol (1), SymBiosis (1), vTv Therapeutics (1), TrivarX (1), Clarity Pharmaceuticals (1), AstraZeneca (1).
Hiring now
Web traffic
Traffic mix: 0% direct, 0% search, 0% social, 0% paid.
What this company is made of
Most common skills at AdvanCell: Research Skills (29), Microsoft Office (27), Communication (26), Project Management (25), Leadership (21), Biotechnology (21), Good Manufacturing Practice (GMP) (19), Clinical Trials (18).
Where the team actually sits
AdvanCell people are concentrated in Queensland, Australia (20), Greater Brisbane Area (9), Australia (8), Massachusetts, United States (5). 5 offices on record.
Search footprint
AdvanCell attracts about 78 organic search visits a month, traffic worth roughly $0K a month if bought through ads. It gained 2 ranking keywords and lost 10 in the last period.
Frequently asked
AdvanCell has 98 employees as of September 2026.
AdvanCell has raised $453M in total, most recently a Series D round in July 2026.
AdvanCell was founded in 2019 by Andrew Adamovich.
Philina Lee (Chief Executive Officer) sits at the top of AdvanCell's reporting structure, with 7 direct reports.
The most common previous employers of current AdvanCell staff are The University of Queensland (10 people), Novartis (5 people), Global Medical Solutions (GMS) (4 people).
Former AdvanCell employees most often move to Varimol (1), SymBiosis (1), vTv Therapeutics (1).
AdvanCell attracts about 78 organic search visits a month, worth roughly $0K a month in equivalent ad spend.
The most common skills among AdvanCell staff are Research Skills, Microsoft Office, Communication, Project Management, Leadership.
AdvanCell staff are concentrated in Queensland, Australia (20), Greater Brisbane Area (9), Australia (8).
AdvanCell has about 35 people in Research, up 17% over the past year, as of September 2026.
AdvanCell has about 14 people in Business Development, up 17% over the past year, as of September 2026.
Computed from 69 current and 23 former AdvanCell profiles, as of September 2026. Source: Crustdata.
Build this for any company
Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.